Last $0.0070 USD
Change Today +0.0022 / 45.83%
Volume 37.3K
As of 10:09 AM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gary A. Lyons

Director, Chairman of Nominating/Governance Committee and Member of Compensation Committee, Vical Incorporated
AgeTotal Calculated CompensationThis person is connected to 32 board members in 5 different organizations across 10 different industries.

See Board Relationships
63$236,000

Background*

Mr. Gary A. Lyons served as President and Chief Executive Officer of Neurocrine Biosciences, Inc. from February 1993 to January 2008. From 1983 to 1993, Mr. Lyons held various executive positions at Genentech Inc., including Vice President of Business Development, Vice President of Sales and Director of Sales & Marketing. He has over 35 years of management experience in the biotechnology and pharmaceutical industries. He served as a Director of Sales at American Critical ...

Read Full Background

Corporate Headquarters*

2215 Bridgepointe Parkway
San Mateo, California 94404

United States

Phone: 650-358-3300
Fax: 650-649-1798

Board Members Memberships*

Former Director
1993-Present
Independent Director and Member of Nominating/Corporate Governance Committee
1997-Present
Director, Chairman of Nominating/Governance Committee and Member of Compensation Committee
1999-2005
Former Director, Chairman of Compensation Committee and Member of Audit Committee
2005-Present
Lead Independent Director, Chairman of Compensation Committee and Member of Finance Committee
2008-2008
Former Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Governance Committee
2008-N/A
Former Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Governance Committee
2009-2012
Former Director
2011-N/A
Former Executive Chairman
2011-Present
Director, Chairman of Compensation Committee and Member of Audit Committee
2013-Present
Independent Director and Member of Governance & Nominating Committee

Education*

BS
The University of New Hampshire, Durham
MBA
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$151,000
Total Calculated Compensation$236,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NGSX:US $0.01 USD +0.0022

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Corporate Secretary and Director
GenVec, Inc.
$316.3K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
--
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEUROGESX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.